Franklyn E. Smith
About Franklyn E. Smith
Franklyn E. Smith (born 1961) is an Independent Director of Neuberger Berman Next Generation Connectivity Fund Inc. (NBXG), serving since 2023. He is a CPA (New York) and spent 32 years at PricewaterhouseCoopers LLP (PwC), including as Market Team leader and Primary Reporting Partner in the New York Asset & Wealth Management Practice; he holds an advanced degree in public accounting . He is currently Vice Chair of NBXG’s Closed-End Funds Committee and Vice Chair of the Contract Review Committee; he attended at least 75% of Board and committee meetings in FY 2024 per the fund’s disclosure .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| PricewaterhouseCoopers LLP | Partner; Market Team leader and Primary Reporting Partner, Asset & Wealth Management Practice (NY) | 1989–2021 | Led reporting for financial services clients; focus on mutual fund clients over last 25 years |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Zurich American Insurance Company | Director | Since 2023 | U.S. insurance subsidiary directorship (listed in proxy “Other Directorships”) |
| Zurich American Life Insurance Company | Director | Since 2023 | Listed in proxy “Other Directorships” |
| Zurich American Life Insurance Company of New York | Director | Since 2023 | Listed in proxy “Other Directorships” |
Board Governance
- Board structure and leadership: Independent Chair (Tom D. Seip); Independent Directors meet outside management; Board met 4 times in FY 2024 .
- Independence and attendance: Smith is an Independent Director. Each Director attended at least 75% of Board and committee meetings in FY 2024 .
- Committee assignments (FY 2024):
- Closed-End Funds Committee: Vice Chair; members = Marc Gary (Chair), Franklyn E. Smith (Vice Chair), Ami G. Kaplan; 7 meetings .
- Contract Review Committee: Vice Chair; members = Deborah C. McLean (Chair), Franklyn E. Smith (Vice Chair), Michael J. Cosgrove, Marc Gary; 7 meetings .
- Investment Performance Committee: All Directors are members; 4 meetings .
- Audit Committee: Not a member (members = Cosgrove (Chair), Goss (Vice Chair), McLean, Nakasone); 7 meetings .
- Ethics & Compliance Committee: Not a member (members = Kaplan (Chair), Knetter (Vice Chair), Gary, Seip); 4 meetings .
- Executive Committee: Not listed as member; Committee did not meet in FY 2024 .
Fixed Compensation
- Complex-wide director pay framework (effective dates):
- Effective Jan 1, 2024: Annual retainer $200,000; $17,500 per regularly scheduled meeting; additional annual fees to Committee Chairs (effective Jan 1, 2025: Contract Review Chair $35,000; other Chairs $25,000); Independent Chair +$90,000; no extra pay for general committee membership .
- Fund-specific and complex totals (most recent disclosures):
- NBXG aggregate compensation to Smith for FY ended Oct 31, 2024: $11,054 .
- Total compensation from registered investment companies in the Neuberger Berman fund complex (CY 2024): $270,000 .
| Compensation Element | Amount | Period | Source |
|---|---|---|---|
| Annual retainer (complex) | $200,000 | Effective 1/1/2024 | |
| Regular meeting fee (per meeting) | $17,500 | Effective 1/1/2024 | |
| Committee Chair fees | Contract Review Chair $35,000; other Chairs $25,000 | Effective 1/1/2025 | |
| Independent Chair premium | $90,000 | Ongoing | |
| NBXG aggregate compensation (Smith) | $11,054 | FY ended 10/31/2024 | |
| Total complex compensation (Smith) | $270,000 | CY 2024 |
Notes: The Funds do not maintain pension or retirement plans for Directors; Independent Director compensation is allocated across funds in the complex; officers/employees of NBIA receive no compensation from the Funds .
Performance Compensation
- No performance-based equity awards (RSUs/PSUs), options, or performance metrics are disclosed for Directors; director pay is cash retainer and meeting fees. No equity compensation plan for Directors is described in the proxy .
| Performance Pay Element | Terms | Source |
|---|---|---|
| Equity awards (RSUs/PSUs) | None disclosed | |
| Stock options | None disclosed | |
| Performance metrics (revenue, EBITDA, TSR, ESG) | None disclosed | |
| Clawback provisions for directors | Not disclosed |
Other Directorships & Interlocks
| Company | Type | Role | Overlap/Interlock Risk |
|---|---|---|---|
| Zurich American Insurance Company; Zurich American Life Insurance Company; Zurich American Life Insurance Company of NY | Insurance subsidiaries | Director (since 2023) | No related-party transactions with NBXG/manager disclosed in proxy; Independent Directors and their immediate families held no NBIA/underwriter securities as of 5/31/2025 |
Expertise & Qualifications
- 32 years at PwC; senior leadership in Asset & Wealth Management audit/reporting; CPA (NY) with advanced degree in public accounting .
- Board service at major insurance subsidiaries (Zurich American group companies) since 2023 .
- Not designated as an “Audit Committee Financial Expert” (those are Cosgrove, Goss, McLean) .
Equity Ownership
- Director share ownership ranges (as of 5/31/2025):
- NBXG: None (Smith holds no NBXG shares) .
- NBH: None .
- Aggregate across all registered funds in Neuberger Berman family: Over $100,000 .
| Holder | NBXG Dollar Range | NBH Dollar Range | Aggregate Dollar Range (All NB Funds) | As-of Date |
|---|---|---|---|---|
| Franklyn E. Smith | None | None | Over $100,000 | 5/31/2025 |
Additional alignment note: As of 5/31/2025, no Independent Director (or immediate family) owned securities of NBIA, any principal underwriter, or affiliates (excludes registered funds) .
Insider Trades (Form 4)
| Date | Transaction | Shares | Price | Source/Notes |
|---|---|---|---|---|
| — | No Form 4 transactions disclosed in proxy materials | — | — | Section 16(a) compliance noted; no director-specific delinquencies disclosed; one late filing pertains to Municipal Fund counterparties, not Smith . |
Governance Assessment
-
Strengths:
- Independent Director with deep audit/financial reporting expertise from PwC; CPA with advanced accounting degree .
- Elevated committee responsibilities: Vice Chair of Closed-End Funds Committee and Contract Review Committee, both of which met seven times in FY 2024—key levers for discount mitigation, contract oversight, advisor reviews, and shareholder value actions .
- Board led by an Independent Chair; all Directors attended ≥75% of Board/committee meetings; independent executive sessions held .
- No related-party transactions or NBIA/underwriter security ownership by Independent Directors (reduces conflicts) .
-
Watch items / potential red flags:
- Ownership alignment: Smith reported “None” for NBXG share ownership as of 5/31/2025, which may be viewed as limited “skin in the game” for a closed-end fund where directors oversee discount mitigation and capital actions .
- Not designated an Audit Committee financial expert (not a red flag per se given his CPA background, but the formal SEC “financial expert” designations reside with Cosgrove, Goss, McLean) .
- The Funds do not have a standing compensation committee (Governance & Nominating handles independent director compensation), which some investors monitor for governance best practices consistency .
-
Context affecting investor confidence:
- Concentrated shareholder base includes activist Saba Capital (9.69% of NBXG as of 3/7/2025) and other significant holders, increasing focus on discount management and governance responsiveness. Smith’s Vice Chair role on the Closed-End Funds Committee is particularly relevant in this environment .
- Board/committees explicitly reference actions historically used to enhance investor value (distribution policy, tenders, leverage structure, strategy changes), aligning with oversight responsibilities of the committees where Smith is Vice Chair .
Appendix: Additional Reference Metrics
- Board meetings FY 2024: 4 .
- Committee meetings FY 2024: Audit 7; Closed-End Funds 7; Contract Review 7; Ethics & Compliance 4; Governance & Nominating 4; Investment Performance 4; Executive 0 .
- Auditor: Ernst & Young LLP; fees and independence oversight summarized in proxy; no conflicts noted .
All citations: .